
Kaynes Technology shares plunged nearly 20% after disappointing September quarter results, with revenue growth slowing to 4% and margins declining by 320 basis points to 13.2%. The company's auditor also raised concerns over its investment in associate firm Iskraemeco, adding to investor uncertainty. Chakri Lokapriya, Managing Partner, RSB LLP, explains why Kaynes Technology's challenges are company-specific and discusses the outlook for the broader EMS sector, including Dixon Technologies and Amber Enterprises. With tariff-related pressures easing but supply chain disruptions and expensive valuations remaining concerns, should investors wait for better valuations or stronger earnings growth before investing?